| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroenterology | 8 | 2020 | 536 | 1.300 |
Why?
|
| Celiac Disease | 10 | 2022 | 785 | 1.240 |
Why?
|
| Fellowships and Scholarships | 7 | 2024 | 1076 | 1.210 |
Why?
|
| Pediatrics | 9 | 2020 | 3475 | 0.880 |
Why?
|
| Education, Medical, Graduate | 6 | 2024 | 2291 | 0.830 |
Why?
|
| Curriculum | 4 | 2024 | 3605 | 0.800 |
Why?
|
| Faculty | 1 | 2024 | 386 | 0.740 |
Why?
|
| Duodenum | 4 | 2019 | 483 | 0.720 |
Why?
|
| Torture | 1 | 2020 | 53 | 0.720 |
Why?
|
| Professional Competence | 2 | 2014 | 447 | 0.710 |
Why?
|
| Endoscopy, Digestive System | 2 | 2019 | 345 | 0.560 |
Why?
|
| Clinical Competence | 6 | 2020 | 4687 | 0.520 |
Why?
|
| Humanism | 1 | 2014 | 89 | 0.440 |
Why?
|
| Faculty, Medical | 2 | 2022 | 1181 | 0.430 |
Why?
|
| Diet, Gluten-Free | 4 | 2022 | 271 | 0.420 |
Why?
|
| Hospitals, Teaching | 1 | 2016 | 1179 | 0.400 |
Why?
|
| Mentors | 1 | 2016 | 631 | 0.400 |
Why?
|
| Crohn Disease | 15 | 2014 | 2303 | 0.370 |
Why?
|
| Education, Medical | 1 | 2020 | 1721 | 0.310 |
Why?
|
| Hospitals, Pediatric | 1 | 2016 | 1775 | 0.300 |
Why?
|
| Colitis, Ulcerative | 15 | 2009 | 1912 | 0.300 |
Why?
|
| Child | 54 | 2024 | 77709 | 0.280 |
Why?
|
| Tacrolimus | 3 | 2000 | 743 | 0.280 |
Why?
|
| Colonoscopy | 4 | 2024 | 1367 | 0.210 |
Why?
|
| Constipation | 2 | 2016 | 546 | 0.190 |
Why?
|
| Needs Assessment | 2 | 2019 | 1147 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 8 | 2004 | 2425 | 0.180 |
Why?
|
| Reference Standards | 1 | 2024 | 1025 | 0.180 |
Why?
|
| Vitamin A Deficiency | 2 | 1998 | 101 | 0.180 |
Why?
|
| National Socialism | 1 | 2020 | 53 | 0.180 |
Why?
|
| Child, Preschool | 35 | 2022 | 41006 | 0.180 |
Why?
|
| Biopsy | 8 | 2019 | 6756 | 0.170 |
Why?
|
| Sex Education | 1 | 2019 | 93 | 0.160 |
Why?
|
| House Calls | 1 | 2020 | 160 | 0.160 |
Why?
|
| Lost to Follow-Up | 1 | 2018 | 105 | 0.160 |
Why?
|
| Vitamin E Deficiency | 1 | 1998 | 32 | 0.160 |
Why?
|
| Immunosuppressive Agents | 3 | 2000 | 4149 | 0.150 |
Why?
|
| Autoimmune Diseases | 5 | 2014 | 2133 | 0.140 |
Why?
|
| Intestinal Mucosa | 6 | 2017 | 3036 | 0.140 |
Why?
|
| Ileocecal Valve | 1 | 1995 | 21 | 0.140 |
Why?
|
| Aminosalicylic Acids | 1 | 1995 | 37 | 0.140 |
Why?
|
| Transglutaminases | 1 | 2017 | 194 | 0.130 |
Why?
|
| Gastroscopy | 1 | 1997 | 207 | 0.130 |
Why?
|
| Diseases in Twins | 2 | 1995 | 449 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2019 | 1590 | 0.130 |
Why?
|
| Colitis | 4 | 1996 | 1170 | 0.130 |
Why?
|
| Immunoglobulin A | 3 | 2017 | 992 | 0.130 |
Why?
|
| Humans | 80 | 2024 | 744343 | 0.130 |
Why?
|
| Ethics, Medical | 1 | 2020 | 792 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1997 | 599 | 0.120 |
Why?
|
| Pancreatin | 1 | 1994 | 9 | 0.120 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 547 | 0.120 |
Why?
|
| Gastrostomy | 1 | 1997 | 309 | 0.120 |
Why?
|
| Adolescent | 42 | 2019 | 85781 | 0.120 |
Why?
|
| Esophagus | 4 | 1999 | 1019 | 0.110 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 2009 | 224 | 0.110 |
Why?
|
| Esophageal and Gastric Varices | 2 | 1995 | 207 | 0.110 |
Why?
|
| Internship and Residency | 3 | 2020 | 5788 | 0.110 |
Why?
|
| Proctocolectomy, Restorative | 2 | 2009 | 189 | 0.110 |
Why?
|
| Nutrition Disorders | 1 | 1994 | 211 | 0.110 |
Why?
|
| Esophagoscopy | 1 | 1995 | 390 | 0.110 |
Why?
|
| Lymphocytosis | 2 | 2008 | 119 | 0.110 |
Why?
|
| Esophagitis | 2 | 1999 | 152 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 1998 | 1130 | 0.110 |
Why?
|
| GTP-Binding Proteins | 1 | 2017 | 970 | 0.110 |
Why?
|
| Receptors, LDL | 2 | 1984 | 475 | 0.100 |
Why?
|
| Autoimmunity | 2 | 2022 | 1349 | 0.100 |
Why?
|
| Intestinal Obstruction | 1 | 1995 | 424 | 0.100 |
Why?
|
| Stomach | 1 | 1996 | 697 | 0.100 |
Why?
|
| Intraoperative Care | 1 | 1995 | 767 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 1049 | 0.100 |
Why?
|
| Colon | 6 | 2008 | 1772 | 0.100 |
Why?
|
| Lipoproteins, LDL | 2 | 1984 | 640 | 0.100 |
Why?
|
| Teaching | 1 | 2019 | 1174 | 0.100 |
Why?
|
| Infant | 25 | 2017 | 35136 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 840 | 0.090 |
Why?
|
| Academic Medical Centers | 2 | 2022 | 2759 | 0.090 |
Why?
|
| Pancreaticoduodenectomy | 1 | 1994 | 503 | 0.090 |
Why?
|
| Female | 50 | 2021 | 380194 | 0.090 |
Why?
|
| Enteritis | 2 | 2008 | 165 | 0.090 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 1177 | 0.090 |
Why?
|
| Food Services | 1 | 2012 | 192 | 0.090 |
Why?
|
| Male | 43 | 2021 | 350118 | 0.090 |
Why?
|
| Antacids | 2 | 2008 | 99 | 0.090 |
Why?
|
| Endoscopy | 2 | 2019 | 1785 | 0.090 |
Why?
|
| Epidermolysis Bullosa, Junctional | 1 | 2008 | 12 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1995 | 868 | 0.080 |
Why?
|
| Integrin beta4 | 1 | 2008 | 31 | 0.080 |
Why?
|
| Parturition | 1 | 2012 | 441 | 0.080 |
Why?
|
| Intestinal Diseases | 2 | 2008 | 530 | 0.080 |
Why?
|
| Digestive System Abnormalities | 1 | 2008 | 52 | 0.080 |
Why?
|
| Pylorus | 1 | 2008 | 86 | 0.080 |
Why?
|
| Lymphocytes | 1 | 1996 | 2617 | 0.080 |
Why?
|
| Colonic Pouches | 1 | 2009 | 121 | 0.080 |
Why?
|
| Anti-Ulcer Agents | 1 | 2008 | 119 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 3508 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2016 | 2488 | 0.080 |
Why?
|
| Gastrointestinal Diseases | 4 | 1998 | 1170 | 0.080 |
Why?
|
| Boston | 2 | 2021 | 9313 | 0.080 |
Why?
|
| Hepatitis, Chronic | 1 | 1987 | 52 | 0.080 |
Why?
|
| Cyclosporins | 1 | 1987 | 220 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2014 | 1821 | 0.070 |
Why?
|
| Checklist | 1 | 2014 | 833 | 0.070 |
Why?
|
| Universities | 1 | 2012 | 956 | 0.070 |
Why?
|
| Diarrhea | 4 | 2008 | 1348 | 0.070 |
Why?
|
| Chilblains | 1 | 2006 | 14 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 15076 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2020 | 53288 | 0.070 |
Why?
|
| Hydronephrosis | 1 | 1987 | 269 | 0.070 |
Why?
|
| Pancreatitis | 2 | 2003 | 1092 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2018 | 3528 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 14722 | 0.070 |
Why?
|
| Wound Healing | 1 | 1997 | 2785 | 0.070 |
Why?
|
| Health Personnel | 1 | 2019 | 3218 | 0.060 |
Why?
|
| Hexosephosphates | 1 | 1984 | 26 | 0.060 |
Why?
|
| Ulcer | 2 | 1997 | 209 | 0.060 |
Why?
|
| Mannosephosphates | 1 | 1984 | 11 | 0.060 |
Why?
|
| Esophageal Diseases | 2 | 1996 | 166 | 0.060 |
Why?
|
| Scoliosis | 1 | 1991 | 725 | 0.060 |
Why?
|
| Remission Induction | 3 | 2000 | 2386 | 0.060 |
Why?
|
| Lovastatin | 1 | 1984 | 120 | 0.060 |
Why?
|
| Adult | 20 | 2018 | 214055 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2886 | 0.060 |
Why?
|
| Fruit | 2 | 1988 | 1142 | 0.060 |
Why?
|
| Procollagen | 3 | 1989 | 185 | 0.060 |
Why?
|
| Pirenzepine | 1 | 2003 | 115 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 424 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2012 | 2684 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 418 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2013 | 3743 | 0.050 |
Why?
|
| United States | 5 | 2020 | 69872 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2003 | 592 | 0.050 |
Why?
|
| Data Collection | 1 | 2010 | 3341 | 0.050 |
Why?
|
| Valproic Acid | 1 | 2003 | 445 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2022 | 328 | 0.050 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2001 | 270 | 0.050 |
Why?
|
| Blood Sedimentation | 2 | 1998 | 231 | 0.050 |
Why?
|
| Endothelial Growth Factors | 2 | 2001 | 694 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2015 | 3749 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3843 | 0.040 |
Why?
|
| Antimanic Agents | 1 | 2003 | 522 | 0.040 |
Why?
|
| Lymphokines | 2 | 2001 | 949 | 0.040 |
Why?
|
| Azathioprine | 1 | 2000 | 353 | 0.040 |
Why?
|
| Pharmaceutical Solutions | 1 | 1998 | 15 | 0.040 |
Why?
|
| Glutens | 1 | 2021 | 230 | 0.040 |
Why?
|
| Interdisciplinary Studies | 1 | 2019 | 89 | 0.040 |
Why?
|
| Competency-Based Education | 1 | 2020 | 211 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2015 | 4558 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1996 | 2214 | 0.040 |
Why?
|
| Gangliosides | 1 | 1999 | 137 | 0.040 |
Why?
|
| Reoperation | 3 | 1997 | 4201 | 0.040 |
Why?
|
| Aluminum | 1 | 1998 | 152 | 0.040 |
Why?
|
| Malabsorption Syndromes | 3 | 1988 | 135 | 0.040 |
Why?
|
| Complementary Therapies | 1 | 2002 | 486 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1580 | 0.040 |
Why?
|
| Sigmoidoscopy | 2 | 1996 | 156 | 0.040 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 302 | 0.040 |
Why?
|
| Proctitis | 1 | 1997 | 40 | 0.040 |
Why?
|
| Hepatitis B virus | 1 | 1981 | 513 | 0.040 |
Why?
|
| Growth | 3 | 1989 | 376 | 0.040 |
Why?
|
| Drug Contamination | 1 | 1998 | 147 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 450 | 0.040 |
Why?
|
| Gastroscopes | 1 | 1997 | 19 | 0.040 |
Why?
|
| Duodenoscopy | 1 | 2017 | 52 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2001 | 3870 | 0.040 |
Why?
|
| Retrospective Studies | 12 | 2021 | 77449 | 0.040 |
Why?
|
| Games, Experimental | 1 | 2016 | 32 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 2408 | 0.030 |
Why?
|
| Hypersensitivity | 2 | 2008 | 1102 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4567 | 0.030 |
Why?
|
| Hepatitis B | 1 | 1981 | 695 | 0.030 |
Why?
|
| Intestines | 2 | 2008 | 1924 | 0.030 |
Why?
|
| Ileal Diseases | 1 | 1995 | 74 | 0.030 |
Why?
|
| Infant, Newborn | 8 | 2017 | 25625 | 0.030 |
Why?
|
| Young Adult | 6 | 2019 | 56430 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 880 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 1996 | 4253 | 0.030 |
Why?
|
| Arteriovenous Malformations | 1 | 1998 | 396 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2019 | 783 | 0.030 |
Why?
|
| Stomach Diseases | 1 | 1996 | 134 | 0.030 |
Why?
|
| Cellulitis | 1 | 1997 | 206 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1996 | 573 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 1996 | 528 | 0.030 |
Why?
|
| Liver Regeneration | 1 | 1996 | 210 | 0.030 |
Why?
|
| Xylose | 1 | 1994 | 28 | 0.030 |
Why?
|
| Vitamin A | 1 | 1998 | 615 | 0.030 |
Why?
|
| 4-Aminobenzoic Acid | 1 | 1994 | 22 | 0.030 |
Why?
|
| Hydroxycholecalciferols | 1 | 1994 | 44 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 854 | 0.030 |
Why?
|
| Equipment Failure | 1 | 1997 | 578 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 1997 | 426 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 1997 | 15295 | 0.030 |
Why?
|
| Ligation | 1 | 1995 | 453 | 0.030 |
Why?
|
| Gastric Emptying | 2 | 1994 | 233 | 0.030 |
Why?
|
| Sclerotherapy | 1 | 1995 | 175 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 3 | 1999 | 782 | 0.030 |
Why?
|
| Odds Ratio | 3 | 2008 | 9849 | 0.030 |
Why?
|
| Vitamin E | 1 | 1998 | 869 | 0.030 |
Why?
|
| Eosinophilia | 2 | 1999 | 541 | 0.030 |
Why?
|
| Laparotomy | 1 | 1995 | 473 | 0.030 |
Why?
|
| Hemangioma | 1 | 1998 | 738 | 0.030 |
Why?
|
| Registries | 1 | 2008 | 8089 | 0.030 |
Why?
|
| Dimerization | 1 | 2014 | 893 | 0.030 |
Why?
|
| Chloroquine | 2 | 1984 | 280 | 0.030 |
Why?
|
| Penetrance | 1 | 2014 | 381 | 0.030 |
Why?
|
| Growth Disorders | 2 | 1997 | 645 | 0.030 |
Why?
|
| Hepatectomy | 1 | 1996 | 550 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 1994 | 420 | 0.030 |
Why?
|
| Prevalence | 1 | 2009 | 15226 | 0.030 |
Why?
|
| Milk Hypersensitivity | 1 | 1993 | 76 | 0.030 |
Why?
|
| Pedigree | 2 | 2014 | 4644 | 0.020 |
Why?
|
| Amylases | 1 | 1991 | 173 | 0.020 |
Why?
|
| Epithelium | 1 | 1996 | 1679 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1999 | 2557 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 1997 | 763 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 1997 | 2971 | 0.020 |
Why?
|
| Asthma | 2 | 2008 | 6011 | 0.020 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 39050 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 6489 | 0.020 |
Why?
|
| Histamine H2 Antagonists | 2 | 2008 | 165 | 0.020 |
Why?
|
| Risk Factors | 5 | 2012 | 72290 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2003 | 3057 | 0.020 |
Why?
|
| Intention | 1 | 2012 | 341 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 9274 | 0.020 |
Why?
|
| Liver | 2 | 2003 | 7474 | 0.020 |
Why?
|
| Mutation | 2 | 2018 | 29786 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 970 | 0.020 |
Why?
|
| Lipase | 1 | 1991 | 314 | 0.020 |
Why?
|
| Severity of Illness Index | 3 | 2002 | 15540 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2001 | 772 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2012 | 1173 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 2559 | 0.020 |
Why?
|
| Hypertension | 2 | 1987 | 8480 | 0.020 |
Why?
|
| Defecation | 1 | 2009 | 188 | 0.020 |
Why?
|
| Breath Tests | 2 | 1988 | 280 | 0.020 |
Why?
|
| Focus Groups | 1 | 2012 | 1321 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2804 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1997 | 2232 | 0.020 |
Why?
|
| Age Factors | 2 | 2018 | 18370 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2014 | 1348 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3271 | 0.020 |
Why?
|
| Food Hypersensitivity | 1 | 1995 | 622 | 0.020 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1987 | 134 | 0.020 |
Why?
|
| Middle Aged | 4 | 2018 | 213383 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1991 | 662 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 1997 | 1540 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 1988 | 264 | 0.020 |
Why?
|
| Pancreas | 1 | 1994 | 1686 | 0.020 |
Why?
|
| Metoclopramide | 1 | 1986 | 51 | 0.020 |
Why?
|
| Carbohydrates | 2 | 1988 | 394 | 0.020 |
Why?
|
| Transaminases | 1 | 1987 | 199 | 0.020 |
Why?
|
| Seasons | 1 | 2012 | 1493 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2007 | 10943 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 1996 | 3200 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2018 | 40561 | 0.020 |
Why?
|
| Treatment Outcome | 6 | 2017 | 63114 | 0.020 |
Why?
|
| Incidence | 2 | 1997 | 20947 | 0.020 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1985 | 51 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4186 | 0.020 |
Why?
|
| Immunoglobulin G | 3 | 2004 | 4560 | 0.020 |
Why?
|
| Sweden | 1 | 2008 | 1345 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2539 | 0.020 |
Why?
|
| Ureteral Obstruction | 1 | 1987 | 296 | 0.020 |
Why?
|
| Phenylpropanolamine | 1 | 1985 | 15 | 0.020 |
Why?
|
| Medicaid | 1 | 2018 | 2736 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 1985 | 156 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4204 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2564 | 0.020 |
Why?
|
| Fasting | 1 | 1991 | 1593 | 0.020 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 1985 | 110 | 0.020 |
Why?
|
| Antibodies, Fungal | 1 | 2004 | 32 | 0.020 |
Why?
|
| Depression | 1 | 2004 | 7766 | 0.020 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1984 | 35 | 0.020 |
Why?
|
| Hydrogen | 1 | 1985 | 164 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 1988 | 5097 | 0.020 |
Why?
|
| Porins | 1 | 2004 | 81 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1984 | 212 | 0.020 |
Why?
|
| Agammaglobulinemia | 1 | 1985 | 167 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 1994 | 1343 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 3923 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1985 | 284 | 0.010 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2008 | 536 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 2008 | 650 | 0.010 |
Why?
|
| Twins | 1 | 1985 | 339 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 693 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 1985 | 458 | 0.010 |
Why?
|
| Naphthalenes | 1 | 1984 | 194 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 1995 | 2119 | 0.010 |
Why?
|
| Proton Pump Inhibitors | 1 | 2008 | 526 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2007 | 881 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4803 | 0.010 |
Why?
|
| Medical Records | 1 | 2008 | 1413 | 0.010 |
Why?
|
| Recurrence | 1 | 1995 | 8340 | 0.010 |
Why?
|
| Proteins | 1 | 1998 | 6103 | 0.010 |
Why?
|
| Motivation | 1 | 2012 | 1971 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1985 | 337 | 0.010 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2004 | 288 | 0.010 |
Why?
|
| Cricetulus | 1 | 1984 | 816 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1984 | 414 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2274 | 0.010 |
Why?
|
| Chewing Gum | 1 | 1981 | 41 | 0.010 |
Why?
|
| Hepatitis B Core Antigens | 1 | 1981 | 92 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1984 | 865 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1984 | 1032 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 57776 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16365 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 2002 | 6365 | 0.010 |
Why?
|
| Cricetinae | 1 | 1984 | 2472 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 1985 | 1011 | 0.010 |
Why?
|
| Internet | 1 | 2012 | 3064 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3336 | 0.010 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1981 | 305 | 0.010 |
Why?
|
| Ovary | 1 | 1984 | 981 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1985 | 740 | 0.010 |
Why?
|
| Steroids | 1 | 2004 | 930 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1988 | 1855 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2001 | 3508 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1981 | 741 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2925 | 0.010 |
Why?
|
| Rectum | 1 | 2004 | 904 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4933 | 0.010 |
Why?
|
| CA-19-9 Antigen | 1 | 1999 | 111 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 1460 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10481 | 0.010 |
Why?
|
| Osteomalacia | 1 | 1998 | 53 | 0.010 |
Why?
|
| Glycoconjugates | 1 | 1999 | 87 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1999 | 414 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3749 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2004 | 1470 | 0.010 |
Why?
|
| Barium Sulfate | 2 | 1992 | 180 | 0.010 |
Why?
|
| Length of Stay | 1 | 1991 | 6309 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2003 | 1101 | 0.010 |
Why?
|
| Quality of Life | 1 | 1999 | 12804 | 0.010 |
Why?
|
| Radioimmunoassay | 2 | 1989 | 919 | 0.010 |
Why?
|
| Intestinal Fistula | 1 | 1997 | 140 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 2505 | 0.010 |
Why?
|
| Models, Biological | 1 | 2012 | 9583 | 0.010 |
Why?
|
| Medical Audit | 1 | 1997 | 467 | 0.010 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1998 | 347 | 0.010 |
Why?
|
| Glycosylation | 1 | 1999 | 1126 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 879 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 1999 | 490 | 0.010 |
Why?
|
| Cholesterol | 1 | 1984 | 2917 | 0.010 |
Why?
|
| Skin | 1 | 2008 | 4364 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 1984 | 2356 | 0.010 |
Why?
|
| Heart Arrest | 1 | 1985 | 1470 | 0.010 |
Why?
|
| Solubility | 1 | 1996 | 1085 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 6459 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2007 | 13989 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1998 | 604 | 0.010 |
Why?
|
| Eosinophils | 1 | 1999 | 955 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2004 | 2585 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1988 | 9146 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 4665 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2752 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 7729 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 1999 | 969 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 163280 | 0.010 |
Why?
|
| Lidocaine | 1 | 1996 | 544 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1996 | 8642 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 4217 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2004 | 25043 | 0.010 |
Why?
|
| Time Factors | 2 | 1991 | 40075 | 0.010 |
Why?
|
| Atrophy | 1 | 1996 | 1583 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1999 | 1738 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1984 | 5021 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 1998 | 1584 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1998 | 990 | 0.010 |
Why?
|
| Cell Line | 1 | 1984 | 15997 | 0.010 |
Why?
|
| Leptin | 1 | 1998 | 1599 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1981 | 3176 | 0.010 |
Why?
|
| Dietary Proteins | 1 | 1995 | 963 | 0.010 |
Why?
|
| Pregnancy | 2 | 2008 | 29144 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1984 | 3255 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 3396 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 8324 | 0.010 |
Why?
|
| Sorbitol | 1 | 1988 | 59 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1985 | 4258 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1996 | 3913 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1984 | 19229 | 0.000 |
Why?
|
| Sucrose | 1 | 1988 | 164 | 0.000 |
Why?
|
| Neoplasms | 1 | 1997 | 21683 | 0.000 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1996 | 3479 | 0.000 |
Why?
|
| Logistic Models | 1 | 2002 | 13408 | 0.000 |
Why?
|
| Fructose | 1 | 1988 | 288 | 0.000 |
Why?
|
| Health Policy | 1 | 1998 | 2661 | 0.000 |
Why?
|
| Reoviridae Infections | 1 | 1985 | 60 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 18111 | 0.000 |
Why?
|
| Gastric Lavage | 1 | 1985 | 18 | 0.000 |
Why?
|
| Sodium Pertechnetate Tc 99m | 1 | 1985 | 57 | 0.000 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1985 | 66 | 0.000 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1985 | 49 | 0.000 |
Why?
|
| Hemiplegia | 1 | 1985 | 135 | 0.000 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1985 | 49 | 0.000 |
Why?
|
| Enema | 1 | 1985 | 141 | 0.000 |
Why?
|
| Hemostatic Techniques | 1 | 1985 | 116 | 0.000 |
Why?
|
| Digestive System | 1 | 1985 | 253 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2001 | 21746 | 0.000 |
Why?
|
| Serologic Tests | 1 | 1985 | 374 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1985 | 676 | 0.000 |
Why?
|
| Disease Progression | 1 | 1999 | 13284 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1985 | 1537 | 0.000 |
Why?
|
| Radiography | 1 | 1992 | 7023 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 2031 | 0.000 |
Why?
|
| Body Mass Index | 1 | 1998 | 12720 | 0.000 |
Why?
|
| Angiography | 1 | 1985 | 1639 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1985 | 1401 | 0.000 |
Why?
|
| Glucose | 1 | 1988 | 4397 | 0.000 |
Why?
|
| Animals | 1 | 1984 | 168757 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1985 | 12959 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1996 | 35421 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1985 | 20129 | 0.000 |
Why?
|